Literature DB >> 29117469

Optimal extent of surgery for early gallbladder cancer with regard to long-term survival: a meta-analysis.

Hongeun Lee1, Wooil Kwon1, Youngmin Han1, Jae Ri Kim1, Sun-Whe Kim1, Jin-Young Jang1.   

Abstract

BACKGROUND: The optimal surgical extent for T1 gallbladder cancer (GBC) remains controversial. Simple cholecystectomy is routinely performed for T1 GBC while several guidelines recommend extended cholecystectomy for T1b GBC. However, evidence regarding the optimal surgical extent for T1 GBC is lacking. This study aims to systematically evaluate the optimal surgical extent for early GBC with regard to long-term survival.
METHODS: A comprehensive literature search in MEDLINE was performed to identify studies with histologically proven GBC and survival data. A total of 22 articles with a total of 2,578 patients were included in the final analysis. Dichotomous data regarding cancer-related death in all T1, T1a, and T1b GBC cases were extracted. Risk ratios, risk differences, and 95% confidence intervals (CIs) were pooled.
RESULTS: The risk ratio between simple and extended cholecystectomy in T1 GBC patients was 1.06 (95% CI 0.97-1.16); T1a, 0.82 (95% CI 0.70-0.96); and T1b, 1.06 (95% CI 0.93-1.22). No significant difference was found according to the extent of surgery in all T1 or T1b GBC cases (P = 0.17 and P = 0.36, respectively). Simple cholecystectomy had significantly lower cancer-related death in T1a GBC patients (P = 0.01).
CONCLUSION: Simple and extended cholecystectomy showed comparable survival outcomes in T1 GBC patients.
© 2017 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Cholecystectomy; Gallbladder neoplasm; Laparoscopic cholecystectomy; Surgical oncology

Mesh:

Year:  2017        PMID: 29117469     DOI: 10.1002/jhbp.521

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  10 in total

Review 1.  The role of PI3K/AKT signaling pathway in gallbladder carcinoma.

Authors:  Zeyu Wu; Xiao Yu; Shuijun Zhang; Yuting He; Wenzhi Guo
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

2.  Diagnostic performance and inter-observer variability to differentiate between T1- and T2-stage gallbladder cancers using multi-detector row CT.

Authors:  Yong Jae Kwon; Kyoung Doo Song; Seong Eun Ko; Jeong Ah Hwang; Minji Kim
Journal:  Abdom Radiol (NY)       Date:  2022-02-22

3.  EGFR-targeted fluorescent imaging using the da Vinci® Firefly™ camera for gallbladder cancer.

Authors:  Jung Ha Choi; Chang Moo Kang; Jeong Youp Park
Journal:  World J Surg Oncol       Date:  2022-06-15       Impact factor: 3.253

4.  Surgical management of biliary malignancy.

Authors:  T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica
Journal:  Curr Probl Surg       Date:  2020-06-30       Impact factor: 1.909

5.  Oncologic Outcomes of Extended Lymphadenectomy without Liver Resection for T1/T2 Gallbladder Cancer.

Authors:  Jae Uk Chong; Woo Jung Lee
Journal:  Yonsei Med J       Date:  2019-12       Impact factor: 2.759

6.  Surgical treatment of gallbladder cancer: An eight-year experience in a single center.

Authors:  Yasuyuki Kamada; Tomohide Hori; Hidekazu Yamamoto; Hideki Harada; Michihiro Yamamoto; Masahiro Yamada; Takefumi Yazawa; Masaki Tani; Asahi Sato; Ryotaro Tani; Ryuhei Aoyama; Yudai Sasaki; Masazumi Zaima
Journal:  World J Hepatol       Date:  2020-09-27

Review 7.  Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients.

Authors:  Patricia García; Angela Lamarca; Javier Díaz; Enrique Carrera; Juan Carlos Roa
Journal:  Cancers (Basel)       Date:  2020-12-07       Impact factor: 6.639

Review 8.  Preoperative Assessment and Perioperative Management of Resectable Gallbladder Cancer in the Era of Precision Medicine and Novel Technologies: State of the Art and Future Perspectives.

Authors:  Gianluca Cassese; Ho-Seong Han; Yoo-Seok Yoon; Jun Suh Lee; Jai Young Cho; Hae-Won Lee; Boram Lee; Roberto Ivan Troisi
Journal:  Diagnostics (Basel)       Date:  2022-07-05

9.  Simple cholecystectomy is an adequate treatment for grade I T1bN0M0 gallbladder carcinoma: Evidence from 528 patients.

Authors:  Jun Shao; Hong-Cheng Lu; Lin-Quan Wu; Jun Lei; Rong-Fa Yuan; Jiang-Hua Shao
Journal:  World J Gastroenterol       Date:  2022-08-21       Impact factor: 5.374

10.  Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T1b gallbladder cancer: An analysis of the surveillance, epidemiology, and end results database (2004 to 2013).

Authors:  Li Xu; Haidong Tan; Xiaolei Liu; Jia Huang; Liguo Liu; Shuang Si; Yongliang Sun; Wenying Zhou; Zhiying Yang
Journal:  Cancer Med       Date:  2020-03-31       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.